Atlantic Edge Private Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24M Sell
17,433
-167
-0.9% -$19.5K 0.46% 49
2026
Q1
$2.12M Buy
17,600
+5,358
+44% +$619K 0.52% 48
2025
Q4
$1.29M Buy
12,242
+309
+3% +$29K 0.32% 63
2025
Q3
$1M Buy
11,933
+37
+0.3% +$3.05K 0.26% 71
2025
Q2
$942K Sell
11,896
-970
-8% -$77.1K 0.26% 74
2025
Q1
$1.15M Sell
12,866
-22
-0.2% -$2.05K 0.35% 67
2024
Q4
$1.28M Sell
12,888
-59
-0.5% -$6.08K 0.4% 61
2024
Q3
$1.47M Buy
12,947
+306
+2% +$36.4K 0.45% 58
2024
Q2
$1.56M Buy
12,641
+357
+3% +$46K 0.52% 48
2024
Q1
$1.62M Buy
12,284
+783
+7% +$96.5K 0.56% 43
2023
Q4
$1.25M Buy
+11,501
New +$1.19M 0.51% 50

Other funds holding MRK

Atlantic Edge Private Wealth Management's MRK Position: Q2 2026 in Review

Atlantic Edge Private Wealth Management reduced its Merck (MRK) stake by 0.95% in Q2 2026, selling an estimated $19.5K and leaving 17,433 shares worth $2.24M. The position accounts for 0.46% of the portfolio, ranked #49.

Atlantic Edge Private Wealth Management first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 1,556 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Atlantic Edge Private Wealth Management held 17,433 shares of Merck worth $2.24M as of Q2 2026.
  • Atlantic Edge Private Wealth Management sold 167 Merck shares in Q2 2026, an estimated $19.5K.
  • Merck made up 0.46% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #49 holding.
  • Atlantic Edge Private Wealth Management first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 1,556 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.